BICALUTAMIDE IN THE HORMONAL THERAPY OF PROSTATE CANCER
The results of clinical trials that evaluated the efficacy, side effects and tolerability of different regimen of application of non-steroid antiandrogene Bicalutamide in the treatment of patients with prostate cancer (PC) were an- alyzed. The data of experimental investigations, which may point to new perspectives for the use of this drug, in particu- lar in treatment of androgenindependent PC, are presented.
No comments » Add comment